Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

<p>Abstract</p> <p>Background</p> <p>Resistance to current chemotherapeutic agents is a major cause of therapy failure in ovarian cancer patients, but the exact mechanisms leading to the development of drug resistance remain unclear.</p> <p>Methods</p>...

Full description

Bibliographic Details
Main Authors: Sherman-Baust Cheryl A, Becker Kevin G, Wood III William H, Zhang Yongqing, Morin Patrice J
Format: Article
Language:English
Published: BMC 2011-12-01
Series:Journal of Ovarian Research
Online Access:http://www.ovarianresearch.com/content/4/1/21